We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.07B
AUM Growth
-$11.6M
Cap. Flow
-$144M
Cap. Flow %
-2.83%
Top 10 Hldgs %
24.83%
Holding
159
New
22
Increased
53
Reduced
27
Closed
17

Top Buys

Rank Stock Value
1
EVH icon
Evolent Health
EVH
+$48.3M
2
FLYW icon
Flywire
FLYW
+$47.9M
3
DLO icon
dLocal
DLO
+$36.1M
4
DV icon
DoubleVerify
DV
+$35.7M
5
SGEN
Seagen Inc. Common Stock
SGEN
+$31.3M

Sector Composition

Rank Sector Weight
1 Healthcare 43.02%
2 Technology 23.53%
3 Industrials 12.87%
4 Consumer Discretionary 5.44%
5 Utilities 4.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTD icon
1
Mettler-Toledo International
MTD
$27.9B
$187M 3.69%
129,621
+7,058
+6% +$9.45M
DOCS icon
2
Doximity
DOCS
$3.82B
$132M 2.6%
3,927,901
+516,614
+15% +$15.8M
TT icon
3
Trane Technologies
TT
$97.3B
$130M 2.56%
771,092
+256
+0% +$42.3K
ODFL icon
4
Old Dominion Freight Line
ODFL
$44.2B
$126M 2.49%
891,384
+286
+0% +$40.6K
ARGX icon
5
argenx
ARGX
$54.6B
$125M 2.46%
328,867
+9,467
+3% +$3.54M
ROP icon
6
Roper Technologies
ROP
$38.5B
$120M 2.37%
278,011
+10,139
+4% +$4.18M
RXDX
7
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$114M 2.24%
1,032,938
-1,636,317
-61% -$106M
HZNP
8
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$113M 2.24%
996,200
+25,000
+3% +$2.08M
WCN
9
Waste Connections
WCN
$41.9B
$107M 2.11%
806,683
+1,413
+0.2% +$192K
IDXX icon
10
Idexx Laboratories
IDXX
$44.1B
$105M 2.07%
257,749
+211
+0.1% +$81.9K
XIFR
11
XPLR Infrastructure LP
XIFR
$1.12B
$102M 2.02%
1,458,142
KRTX
12
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$102M 2.01%
519,700
PANW icon
13
Palo Alto Networks
PANW
$265B
$98.7M 1.95%
1,415,160
+17,012
+1% +$1.37M
FLYW icon
14
Flywire
FLYW
$2.01B
$98.5M 1.94%
4,025,288
+2,224,921
+124% +$47.9M
GTM
15
ZoomInfo Technologies
GTM
$978M
$96.6M 1.9%
3,207,158
+674,460
+27% +$23.3M
ASND icon
16
Ascendis Pharma A/S
ASND
$16.5B
$95.6M 1.89%
782,709
-416,291
-35% -$48.3M
DLO icon
17
dLocal
DLO
$4.41B
$93.4M 1.84%
5,995,926
+2,052,523
+52% +$36.1M
EXAS
18
DELISTED
Exact Sciences
EXAS
$92.5M 1.82%
1,867,365
LOW icon
19
Lowe's Companies
LOW
$118B
$89.4M 1.76%
448,883
+10,916
+2% +$2.18M
POOL icon
20
Pool Corp
POOL
$6.95B
$74.7M 1.47%
247,100
FIVN icon
21
FIVE9
FIVN
$2.12B
$70.8M 1.4%
1,042,851
-312,149
-23% -$19.6M
DV icon
22
DoubleVerify
DV
$1.69B
$70.7M 1.39%
3,218,895
+1,371,751
+74% +$35.7M
XMTR icon
23
Xometry
XMTR
$4.69B
$67.8M 1.34%
2,103,232
+488,134
+30% +$22.8M
APTV icon
24
Aptiv
APTV
$12.3B
$67.1M 1.32%
720,379
+232
+0% +$22.1K
TTD icon
25
Trade Desk
TTD
$8.59B
$65.7M 1.3%
1,464,957
-368,543
-20% -$18.7M

Similar funds

Eventide Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Eventide Asset Management held 159 positions worth $5.07B, down 0.23% from $5.08B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Eventide Asset Management's Q4 2022 filing shows 22 new, 53 increased, 27 reduced and 17 closed positions. Its largest new stake was Seagen Inc. Common Stock: 242,545 shares worth $31.2M. The largest sale was Cintas, an estimated $108M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 39% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q4 2022 buy was Seagen Inc. Common Stock: 242,545 shares worth $31.2M.
  • Eventide Asset Management added most to Evolent Health in Q4 2022, an estimated $48.3M increase.
  • Eventide Asset Management's biggest Q4 2022 reduction was Prometheus Biosciences, Inc. Common Stock, cutting an estimated $106M.
  • Eventide Asset Management fully exited Cintas in Q4 2022, selling an estimated $108M.
  • Eventide Asset Management's ten largest holdings make up 25% of its $5.07B portfolio in Q4 2022.
  • Eventide Asset Management opened 22 new positions and closed 17 in Q4 2022.
  • Eventide Asset Management's portfolio value fell 0.23% quarter-over-quarter to $5.07B.

Based on Eventide Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.